Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF

Jennifer E. Huffman(National Heart Lung and Blood Institute), Paul S. de Vries(Erasmus MC), Alanna C. Morrison(The University of Texas Health Science Center at Houston), Maria Sabater‐Lleal(Karolinska Institutet), Tim Kacprowski(Universität Greifswald), Paul L. Auer(University of Wisconsin–Milwaukee), Jennifer A. Brody(University of Washington), Daniel I. Chasman(Brigham and Women's Hospital), Ming-Huei Chen(Boston University), Xiuqing Guo(University of California, Los Angeles), Li‐An Lin(Brown Foundation), Riccardo E. Marioni(The University of Queensland), Martina Müller‐Nurasyid(Helmholtz Zentrum München), Lisa R. Yanek(Johns Hopkins University), Nathan Pankratz(University of Minnesota), Megan L. Grove(The University of Texas Health Science Center at Houston), Moniek P.M. de Maat(Erasmus MC), Mary Cushman(University of Vermont), Kerri L. Wiggins(University of Washington), Lihong Qi(University of California, Davis), Bengt Sennblad(Science for Life Laboratory), Sarah E. Harris(Institute of Genetics and Cancer), Ozren Polašek(University of Split), Helene Riess(Universität Ulm), Fernando Rivadeneira(Erasmus MC), Lynda M. Rose(Brigham and Women's Hospital), Anuj Goel(John Radcliffe Hospital), Kent D. Taylor(University of California, Los Angeles), Alexander Teumer(Universitätsmedizin Greifswald), André G. Uitterlinden(Erasmus MC), Dhananjay Vaidya(Johns Hopkins University), Jie Yao(The Lundquist Institute), Weihong Tang(University of Minnesota), Daniel Levy(National Heart Lung and Blood Institute), Mélanie Waldenberger(Helmholtz Zentrum München), Diane M. Becker(Johns Hopkins University), Aaron R. Folsom(University of Minnesota), Franco Giulianini(Brigham and Women's Hospital), Andreas Greinacher(Universitätsmedizin Greifswald), Albert Hofman(Erasmus MC), Chiang‐Ching Huang(University of Wisconsin–Milwaukee), Charles Kooperberg(Fred Hutch Cancer Center), Angela Silveira(Karolinska Institutet), John M. Starr(Alzheimer Scotland), Konstantin Strauch(Helmholtz Zentrum München), Rona J. Strawbridge(Karolinska Institutet), Alan F. Wright(Institute of Genetics and Cancer), Barbara McKnight(University of Washington), Oscar H. Franco(Erasmus MC), Neil A. Zakai(University of Vermont), Rasika A. Mathias(Johns Hopkins University), Bruce M. Psaty(Group Health Cooperative), Paul M. Ridker(Brigham and Women's Hospital), Geoffrey H. Tofler(The University of Sydney), Uwe Völker(Universität Greifswald), Hugh Watkins(John Radcliffe Hospital), Myriam Fornage(Brown Foundation), Anders Hamsten(Karolinska Institutet), Ian J. Deary(University of Edinburgh), Eric Boerwinkle(Baylor College of Medicine), Wolfgang Köenig(Universität Ulm), Jerome I. Rotter(University of California, Los Angeles), Caroline Hayward(Institute of Genetics and Cancer), Abbas Dehghan(Erasmus MC), Alex P. Reiner(Fred Hutch Cancer Center), Christopher J. O’Donnell(National Heart Lung and Blood Institute), Nicholas L. Smith(Group Health Cooperative)
Cited by 80Open Access
Full Text

Abstract

Fibrinogen, coagulation factor VII (FVII), and factor VIII (FVIII) and its carrier von Willebrand factor (vWF) play key roles in hemostasis. Previously identified common variants explain only a small fraction of the trait heritabilities, and additional variations may be explained by associations with rarer variants with larger effects. The aim of this study was to identify low-frequency (minor allele frequency [MAF] ≥0.01 and <0.05) and rare (MAF <0.01) variants that influence plasma concentrations of these 4 hemostatic factors by meta-analyzing exome chip data from up to 76,000 participants of 4 ancestries. We identified 12 novel associations of low-frequency (n = 2) and rare (n = 10) variants across the fibrinogen, FVII, FVIII, and vWF traits that were independent of previously identified associations. Novel loci were found within previously reported genes and had effect sizes much larger than and independent of previously identified common variants. In addition, associations at KCNT1, HID1, and KATNB1 identified new candidate genes related to hemostasis for follow-up replication and functional genomic analysis. Newly identified low-frequency and rare-variant associations accounted for modest amounts of trait variance and therefore are unlikely to increase predicted trait heritability but provide new information for understanding individual variation in hemostasis pathways.


Related Papers

No related papers found

Powered by citation graph analysis